WORK Medical Technology Group (NASDAQ:WOK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of WORK Medical Technology Group (NASDAQ:WOK) to a hold rating in a report published on Friday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of WORK Medical Technology Group in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

WORK Medical Technology Group Stock Performance

Shares of WORK Medical Technology Group stock opened at $5.71 on Friday. The stock’s 50-day simple moving average is $8.70 and its 200-day simple moving average is $53.03. WORK Medical Technology Group has a 52 week low of $2.79 and a 52 week high of $844.63.

Institutional Investors Weigh In On WORK Medical Technology Group

A hedge fund recently bought a new stake in WORK Medical Technology Group stock. Sabby Management LLC purchased a new stake in shares of WORK Medical Technology Group LTD (NASDAQ:WOK) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,724,004 shares of the company’s stock, valued at approximately $204,000. WORK Medical Technology Group makes up about 0.2% of Sabby Management LLC’s investment portfolio, making the stock its 18th biggest position. Sabby Management LLC owned about 590.89% of WORK Medical Technology Group as of its most recent SEC filing.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.